Merriman Curhan Ford Initiates Coverage on Brightpoint (CELL) with a Buy; Revised Outlook Offers an Entry Point
Tweet Send to a Friend
Merriman Curhan Ford initiates coverage on Brightpoint (Nasdaq: CELL) with a Buy rating.
Merriman analyst says, "Brightpoint is the leading ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Merriman analyst says, "Brightpoint is the leading ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
